Low Levels of Cortisol are Associated with HIV Infection in Older People: A Hormonal Substudy in the OVER50 Cohort


Cite item

Full Text

Abstract

Introduction:People with the human immunodeficiency virus (PWH) who were diagnosed long ago are more prone to age-related conditions and comorbidities than the general population. We hypothesized that older PWH have endocrine abnormalities that may influence the patient’s health status.

Methods:Mean hormonal values across the thyrotropic, somatotropic, corticotropic, and gonadal axis, and percentage of subjects with abnormal values, were compared between PWH aged ≥50 years (n=30) and people without HIV (n=30) (Over50 cohort). Clinical factors were also analyzed as independent variables.

Results:PWH had a higher prevalence of comorbidities (36.67% PWH and 20.69% controls had ≥3 comorbidities). Male PWH exhibited lower estradiol levels than male controls (29.75±7.68 pg/mL vs. 35.45±10.04 pg/mL; p=0.0041). Abnormal concentrations of testosterone were found in 35% of male PWH compared to 55% of male controls (mostly above reference values). Cortisol levels were significantly lower among PWH (9.97±4.33 µg/dL vs. 13.56±3.39 µg/dL; p=0.002); 16.6% of PWH exhibited abnormally low levels (<5 µg/dL), compared to 0% of controls, and 3 PWH met criteria for a definitive diagnosis of adrenal insufficiency (<3.6 µg/dL). For the somatotropic axis, growth hormone (GH) levels were significantly lower in male PWH than in controls (p=0.0394). No significant differences were found in relation to the thyroid axis.

Conclusion:Hormones are generally similar between the chronic PWH who are receiving ART treatment and the general control population, except for cortisol in both sexes and testosterone and estradiol in men. Some special attention should be given to cortisol in PWH due to a presumably higher risk of adrenal complications.

About the authors

Diana Hernandez-Sanchez

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Author for correspondence.
Email: info@benthamscience.net

Silvia Martinez-Couselo

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Manel Puig-Domingo

Department of Biochemistry, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Ana Martinez

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Sandra Gonzalez

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Patricia Echeverria

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Anna Bonjoch

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Jordi Puig

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

Eugenia Negredo

Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol

Email: info@benthamscience.net

References

  1. van den Beld AW, Kaufman JM, Zillikens MC, Lamberts SWJ, Egan JM, van der Lely AJ. The physiology of endocrine systems with ageing. Lancet Diabetes Endocrinol 2018; 6(8): 647-58. doi: 10.1016/S2213-8587(18)30026-3 PMID: 30017799
  2. Zaid D, Greenman Y. Human immunodeficiency virus infection and the endocrine system. Endocrinol Metab (Seoul) 2019; 34(2): 95-105. doi: 10.3803/EnM.2019.34.2.95 PMID: 31257738
  3. Mirza FS, Luthra P, Chirch L. Endocrinological aspects of HIV infection. J Endocrinol Invest 2018; 41(8): 881-99. doi: 10.1007/s40618-017-0812-x PMID: 29313284
  4. Negredo E, Loste C, Puig J, et al. Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort). AIDS Care 2022; 34(2): 155-62. doi: 10.1080/09540121.2021.1998314 PMID: 34743624
  5. Raghavan A, Rimmelin DE, Fitch KV, Zanni MV. Sex differences in select non-communicable HIV-associated comorbidities: Exploring the role of systemic immune activation/inflammation. Curr HIV/AIDS Rep 2017; 14(6): 220-8. doi: 10.1007/s11904-017-0366-8 PMID: 29080122
  6. Milman S, Huffman DM, Barzilai N. The somatotropic axis in human aging: Framework for the current state of knowledge and future research. Cell Metab 2016; 23(6): 980-9. doi: 10.1016/j.cmet.2016.05.014 PMID: 27304500
  7. Stanley TL, Fourman LT, Wong LP, et al. Growth hormone releasing hormone reduces circulating markers of immune activation in parallel with effects on hepatic immune pathways in individuals with HIV-infection and nonalcoholic fatty liver disease. Clin Infect Dis 2021; 73(4): 621-30. doi: 10.1093/cid/ciab019 PMID: 33852720
  8. Fourman LT, Czerwonka N, Shaikh SD, et al. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS 2018; 32(7): 927-32. PMID: 29424780
  9. Patterson S, Moran P, Epel E. Cortisol patterns are associated with T cell activation in HIV. PLoS One 2013; 8(7): e63429. doi: 10.1371/journal.pone.0063429
  10. Norbiato G. Endocrine, metabolic, and immunologic components of HIV infection. Ann N Y Acad Sci 2012; 1262(1): 51-5. doi: 10.1111/j.1749-6632.2012.06620.x PMID: 22823435
  11. Akase IE, Habib AG, Bakari AG, et al. Occurrence of hypocortisolism in HIV patients: Is the picture changing? Ghana Med J 2018; 52(3): 147-52. doi: 10.4314/gmj.v52i3.7 PMID: 30602800
  12. Dutta D, Sharma N, Sharma LK, et al. Presence, patterns & predictors of hypocortisolism in patients with HIV infection in India. Indian J Med Res 2018; 147(2): 142-50. doi: 10.4103/ijmr.IJMR_43_16 PMID: 29806602
  13. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101(2): 364-89. doi: 10.1210/jc.2015-1710 PMID: 26760044
  14. Miguel Novoa P, Vela ET, García NP, et al. Guide for the diagnosis and treatment of adrenal insufficiency in adults. Endocrinol Nutr 2014; 61: 1-35. doi: 10.1016/S1575-0922(14)73526-0 PMID: 25128212
  15. Nassoro DD, Mkhoi ML, Sabi I, Meremo AJ, Lawala PS, Mwakyula IH. Adrenal insufficiency: A forgotten diagnosis in HIV/AIDS patients in developing countries. Int J Endocrinol 2019; 2019: 2342857. doi: 10.1155/2019/2342857
  16. Swann SA, King EM, Côté HCF, Murray MCM. Stressing the need for validated measures of cortisol in HIV research: A scoping review. HIV Med 2022; 23(8): 880-94. doi: 10.1111/hiv.13272 PMID: 35343039
  17. Madeddu G, Spanu A, Chessa F, et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol (Oxf) 2006; 64(4): 375-83. doi: 10.1111/j.1365-2265.2006.02472.x PMID: 16584508
  18. Dev N, Sahoo R, Kulshreshtha B, Gadpayle AK, Sharma SC. Prevalence of thyroid dysfunction and its correlation with CD4 count in newly-diagnosed HIV-positive adults – a cross-sectional study. Int J STD AIDS 2015; 26(13): 965-70. doi: 10.1177/0956462414563776 PMID: 25505045
  19. Properzi M, della Giustina T, Mentasti S, et al. Low prevalence of symptomatic thyroid diseases and thyroid cancers in HIV-infected patients. Sci Rep 2019; 9(1): 19459. doi: 10.1038/s41598-019-56032-7 PMID: 31857648
  20. Ji S, Jin C, Höxtermann S. Prevalence and influencing factors of thyroid dysfunction in hiv-infected patients. Biomed Res Int 2016; 2016: 3874257. doi: 10.1155/2016/3874257
  21. Emokpae MA, Akinnuoye IM. Asymptomatic thyroid dysfunction in human immunodeficiency virus-1-infected subjects. J Lab Physicians 2018; 10(2): 130-4. doi: 10.4103/JLP.JLP_172_16 PMID: 29692575

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Bentham Science Publishers